Allinaire Therapeutics

Developing novel therapeutics for cardiopulmonary diseases, including PAH and COPD

placeCleveland, Ohio, United States calendar_todayFounded 2016 groups4 employees language allinaire.com

Registered entities

Investor mix

5 investors on record; lead investors include BioMotiv, BioCrossroads.

Investor typeCountShare
Venture capital240%
Accelerator & incubator120%
Other / undisclosed240%
Coming soon